Hematopoietic Cell Transplant for Sickle Cell Disease (HCT for SCD)

Request Access

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.

E. Gluckman, B. Cappelli, F. Bernaudin, et al.. (2017). Blood. Cited 399 times. https://doi.org/10.1182/blood-2016-10-745711

Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

N. Kamani, M. Walters, S. Carter, et al.. (2012). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Cited 190 times. https://doi.org/10.1016/j.bbmt.2012.01.019

Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research

J. Panepinto, M. Walters, J. Carreras, et al.. (2007). British Journal of Haematology. Cited 168 times. https://doi.org/10.1111/j.1365-2141.2007.06592.x

Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.

M. Eapen, R. Brazauskas, M. Walters, et al.. (2019). The Lancet. Haematology. Cited 136 times. https://doi.org/10.1016/S2352-3026(19)30154-1

Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease.

Allistair A. Abraham, M. Hsieh, M. Eapen, et al.. (2017). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Cited 75 times. https://doi.org/10.1016/j.bbmt.2017.08.038

Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study

L. Krishnamurti, D. Neuberg, K. Sullivan, et al.. (2019). American Journal of Hematology. Cited 67 times. https://doi.org/10.1002/ajh.25401

Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study.

E. Atallah, B. Logan, Min Chen, et al.. (2019). JAMA oncology. Cited 48 times. https://doi.org/10.1001/jamaoncol.2019.5140

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.

R. Brazauskas, G. Scigliuolo, Hai-lin Wang, et al.. (2020). Blood. Cited 38 times. https://doi.org/10.1182/blood.2020005687
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747